plerixafor has been researched along with Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, J; Fan, X; Ge, S; He, J; Jia, R; Li, C; Li, P; Wang, Y; Zhang, H | 1 |
Hwang, ST; Takekoshi, T; Volkman, BF; Ziarek, JJ | 1 |
Ascierto, PA; Botti, G; Calemma, R; Caracò, C; Castello, G; Castiglia, D; De Michele, I; Franco, R; Giuliano, P; Ieranò, C; Lombardi, ML; Luongo, M; Mauro, F; Napolitano, M; Nicoletti, G; Ottaiano, A; Satriano, RA; Scala, S; Simeone, E | 1 |
3 other study(ies) available for plerixafor and Melanoma
Article | Year |
---|---|
The SDF-1/CXCR4 chemokine axis in uveal melanoma cell proliferation and migration.
Topics: Benzylamines; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Cyclams; Gene Expression; Heterocyclic Compounds; Humans; Melanoma; Receptors, CXCR4; Uveal Neoplasms | 2016 |
A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability.
Topics: Animals; Benzylamines; Calcium; Cell Proliferation; Chemokine CXCL12; Cyclams; Dipeptidyl Peptidase 4; Heterocyclic Compounds; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Melanoma; Mice; Mice, Inbred C57BL; Protein Multimerization; Protein Stability; Receptors, CXCR4; Serum | 2012 |
Human melanoma metastases express functional CXCR4.
Topics: Benzylamines; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Chemokines, CXC; Cyclams; Enzyme Activation; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Immunohistochemistry; Melanoma; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptors, Chemokine; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; Skin; Time Factors | 2006 |